top of page

BURINOSE

Bumetanide nasal spray for treatment of decompensated hear failure

heart failure

symptoms due to reduced pumping function

medication: reduction of symptoms, against fluid and salt retention and better prognosis

 

decompensated heart failure (decompensatio cordis)

→ (worsening of) symptoms due to salt and water retention, edema formation

​
treatment options:

oral (PO) diuretics: decreased effectiveness (diuretic resistance)

intravenous (IV) diuretics: effective but hospital admission required (high costs, displacement of other care, infections and mental burden)

 
How can we effectively treat patients at home?

the challenge of treating decompensated heart failure effectively in an outpatient setting when oral diuretics lose effectiveness but IV diuretics require hospitalization.

turning the tide in congestive heart failure 26-6-2025.png
IP 

2021         WO2023285009 (A1) aqueous bumetanide solutions

                  achieving stable 1mg/50 ul bumetanide solutions with better than oral pk/pd

                  to be validated july-august 2025

 

2024         Achieving PK/PD close to IV with nasal application

                  

2025         Achieving PK/PD close to IV with nasal application

​

bottom of page